ilmscore | Prediction Details
"Even if I am talking about q2 fy2 versus 25 the percentage has gone up from 34 to 35"
By CA Rachana Phadke Ranade | January 22, 2025 | Pending
From video
Mankind Pharma: Fundamental Analysis | Stocks in Focus - Part 3 | CA Rachana Ranade 00:09:12 - 00:09:15
Interpreted Prediction
Mankind Pharma's chronic disease market share increased from 34% in Q2 FY25 to 35% in Q2 FY26.

Prediction Details

Ticker
MANKIND

Comments

0 comments

Be the first to share your thoughts.

Like this prediction?

Join to make your opinion count.